Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Metab Brain Dis ; 38(4): 1261-1272, 2023 04.
Article in English | MEDLINE | ID: mdl-36735154

ABSTRACT

The blackberry (Rubus sp.) is a popular fruit that has a high concentration of phenolic compounds. Pharmacological investigations have demonstrated the important biological activities of the blackberry extract, such as neuroprotective actions. This study aimed to evaluate the effects of blackberry extract on memory and neurochemical parameters in rats subjected to scopolamine (SCO)-induced amnesia. Male rats were divided into five groups: I, control (saline); II, SCO; III, SCO + Rubus sp. (100 mg/kg); IV, SCO + Rubus sp. (200 mg/kg); and V, SCO + donepezil (5 mg/kg). Blackberry extract and donepezil were orally administered for 10 days. On day 11, group I received saline, and groups II, III, IV, and V received SCO (1 mg/kg) intraperitoneally after object recognition behavioral training. Twenty-four hours after the training session, animals were subjected to an object recognition test. Finally, the animals were euthanized, and the cerebral cortex, hippocampus, and cerebellum were collected to evaluate the oxidative stress and acetylcholinesterase (AChE) activity. Rubus sp. extract prevented memory impairment induced by SCO in a manner similar to that of donepezil. Additionally, Rubus sp. extract and donepezil prevented the increase in AChE activity induced by SCO in all the evaluated brain structures. SCO induced oxidative damage in the cerebral cortex, hippocampus, and cerebellum, which was prevented by Rubus sp. and donepezil. Our results suggest that the antioxidant and anticholinesterase activities of Rubus sp. are associated with memory improvement; hence, it can potentially be used for the treatment of neurodegenerative diseases.


Subject(s)
Rubus , Rats , Male , Animals , Rubus/metabolism , Acetylcholinesterase/metabolism , Donepezil/pharmacology , Donepezil/therapeutic use , Amnesia/chemically induced , Amnesia/drug therapy , Amnesia/prevention & control , Memory Disorders/drug therapy , Memory Disorders/chemically induced , Scopolamine/pharmacology , Hippocampus/metabolism , Cerebral Cortex/metabolism , Oxidative Stress , Antioxidants/pharmacology , Cerebellum/metabolism , Maze Learning
2.
Biomarkers ; 28(2): 238-248, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36576409

ABSTRACT

Objective: In this study, we aimed to determine the role of Psidium cattleianum extract (PCE) and compare its effects with those of metformin (Met) in an animal model with type 2 diabetes mellitus (T2DM).Methods: T2DM was induced in rats using a high-fat diet (HFD), followed by a single dose of streptozotocin (STZ). Met and PCE were administered intragastrically once a day throughout the experiment, and their effects on biochemical, inflammatory, oxidative, and histological parameters were evaluated.Results: Met and PCE prevented the increase in serum levels of glucose, total cholesterol (TC), triacylglycerol (TG), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) induced by T2DM, and restored redox homeostasis in the liver and brain. Met increased the serum levels of anti-inflammatory cytokine and interleukin-10 (IL-10). Furthermore, both treatments restored the liver and pancreas from marked cellular disorganisation, vacuolisation, and necrosis, with PCE being more effective than Met in recovering histological changes.Conclusion: PCE is a promising agent for the prevention of T2DM complications.


Subject(s)
Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Metformin , Psidium , Animals , Rats , Blood Glucose , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/pathology , Fruit , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Metformin/therapeutic use , Models, Animal
3.
Neurochem Res ; 47(2): 446-460, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34623562

ABSTRACT

This study investigated the effects of inosine on memory acquisition and consolidation, cholinesterases activities, redox status and Na+, K+-ATPase activity in a rat model of scopolamine-induced cognitive impairment. Adult male rats were divided into four groups: control (saline), scopolamine (1 mg/kg), scopolamine plus inosine (50 mg/kg), and scopolamine plus inosine (100 mg/kg). Inosine was pre-administered for 7 days, intraperitoneally. On day 8, scopolamine was administered pre (memory acquisition protocol) or post training (memory consolidation protocol) on inhibitory avoidance tasks. The animals were subjected to the step-down inhibitory avoidance task 24 hours after the training. Scopolamine induced impairment in the acquisition and consolidation phases; however, inosine was able to prevent only the impairment in memory consolidation. Also, scopolamine increased the activity of acetylcholinesterase and reduced the activity of Na+, K+-ATPase and the treatment with inosine protected against these alterations in consolidation protocol. In the animals treated with scopolamine, inosine improved the redox status by reducing the levels of reactive oxygen species and thiobarbituric acid reactive substances and restoring the activity of the antioxidant enzymes, superoxide dismutase and catalase. Our findings suggest that inosine may offer protection against scopolamine-induced memory consolidation impairment by modulating brain redox status, cholinergic signaling and ion pump activity. This compound may provide an interesting approach in pharmacotherapy and as a prophylactic against neurodegenerative mechanisms involved in Alzheimer's disease.


Subject(s)
Cognitive Dysfunction , Memory Consolidation , Acetylcholinesterase/metabolism , Animals , Cholinergic Agents/adverse effects , Inosine/adverse effects , Ion Pumps/pharmacology , Ion Pumps/therapeutic use , Male , Maze Learning , Memory Disorders/chemically induced , Memory Disorders/drug therapy , Memory Disorders/prevention & control , Oxidation-Reduction , Oxidative Stress , Rats , Rats, Wistar , Scopolamine/pharmacology
4.
Mol Cell Endocrinol ; 524: 111157, 2021 03 15.
Article in English | MEDLINE | ID: mdl-33421531

ABSTRACT

Both the cholinergic pathway and oxidative stress are important mechanisms involved in the pathogenesis of hypothyroidism, a condition characterized by low levels of thyroid hormone that predispose the patient to brain dysfunction. Phenolic compounds have numerous health benefits, including antioxidant activity. This study evaluates the preventive effects of resveratrol in the cholinergic system and redox status in rats with methimazole-induced hypothyroidism. Hypothyroidism increases acetylcholinesterase (AChE) activity and density in the cerebral cortex and hippocampus and decreases the α7 and M1 receptor densities in the hippocampus. Hypothyroidism also increases cellular levels of reactive oxygen species (ROS) and thiobarbituric acid reactive substances (TBARS), but reduces total thiol content, and catalase and superoxide dismutase activities in the serum. In the cerebral cortex and hippocampus, hypothyroidism increases the levels of ROS and nitrites. In this study, resveratrol (50 mg/kg) treatment prevents the observed increase in AChE in the cerebral cortex, and increases the protein levels of NeuN, a marker of mature neurons. Resveratrol also prevents changes in serum ROS levels and brain structure, as well as the levels of TBARS, total thiol content, and serum catalase enzyme activity. These collective findings suggest that resveratrol has a high antioxidant capacity and can restore hypothyroidism-triggered alterations related to neurotransmission. Thus, it is a promising agent for the prevention of brain damage resulting from hypothyroidism.


Subject(s)
Cholinergic Agents/metabolism , Hypothyroidism/metabolism , Hypothyroidism/pathology , Neuroprotection/drug effects , Resveratrol/pharmacology , Signal Transduction , Acetylcholinesterase/metabolism , Animals , Antigens, Nuclear/metabolism , Disease Models, Animal , Glial Fibrillary Acidic Protein/metabolism , Hippocampus/metabolism , Hypothyroidism/blood , Male , Nerve Tissue Proteins/metabolism , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Rats, Wistar , Receptors, Cholinergic/metabolism , Signal Transduction/drug effects , Thyroxine/blood , Triiodothyronine/blood
5.
Int J Epidemiol ; 50(1): 256-265, 2021 03 03.
Article in English | MEDLINE | ID: mdl-32888008

ABSTRACT

BACKGROUND: Ultra-processed food consumption and obesity have been highlighted as an important relationship to public health. We aimed to evaluate the association between ultra-processed food consumption and body fat from 6 to 11 years of age. METHODS: We assessed the association between ultra-processed food consumption (from food frequency questionnaires) and body fat (measured by air displacement plethysmography) between 6 and 11 years of age among participants of the Pelotas-Brazil 2004 Birth Cohort. The NOVA classification was used to classify foods according to the processing degree. Body fat was evaluated relative to the height using fat mass index (FMI). Generalized estimating equations were used to answer the main research question and mediation analyses were run to assess the direct and indirect effect of ultra-processed food in body fat. RESULTS: At fully adjusted analysis, an increase of 100 g in contribution from ultra-processed food to daily food intake at between 6 and 11 years of age was associated with a gain of 0.14 kg/m² in FMI in the same period; 58% of the total effect of ultra-processed food intake at 6 years (in grams) over the change in FMI from 6 to 11 years was mediated by its calorie content. CONCLUSIONS: Ultra-processed food consumption was associated with an increase in body fat from childhood to early adolescence, and this association was not just due to the effect of ultra-processed food on calorie content.


Subject(s)
Energy Intake , Fast Foods , Adolescent , Brazil , Child , Cohort Studies , Diet , Humans , Obesity
6.
Amino Acids ; 52(11-12): 1545-1558, 2020 Dec.
Article in English | MEDLINE | ID: mdl-33184691

ABSTRACT

We investigated the ability of tannic acid (TA) to prevent oxidative and nitrosative damage in the brain, liver, kidney, and serum of a rat model of acute hypermethioninemia. Young Wistar rats were divided into four groups: I (control), II (TA 30 mg/kg), III (methionine (Met) 0.4 g/kg + methionine sulfoxide (MetO) 0.1 g/kg), and IV (TA/Met + MetO). Rats in groups II and IV received TA orally for seven days, and rats of groups I and III received an equal volume of water. After pretreatment with TA, rats from groups II and IV received a single subcutaneous injection of Met + MetO, and were euthanized 3 h afterwards. In specific brain structures and the kidneys, we observed that Met + MetO led to increased reactive oxygen species (ROS), nitrite, and lipid peroxidation levels, followed by a reduction in thiol content and antioxidant enzyme activity. On the other hand, pretreatment with TA prevented both oxidative and nitrosative damage. In the serum, Met + MetO caused a decrease in the activity of antioxidant enzymes, which was again prevented by TA pretreatment. In contrast, in the liver, there was a reduction in ROS levels and an increase in total thiol content, which was accompanied by a reduction in catalase and superoxide dismutase activities in the Met + MetO group, and pretreatment with TA was able to prevent only the reduction in catalase activity. Conclusively, pretreatment with TA has proven effective in preventing oxidative and nitrosative changes caused by the administration of Met + MetO, and may thus represent an adjunctive therapeutic approach for treatment of hypermethioninemia.


Subject(s)
Amino Acid Metabolism, Inborn Errors/drug therapy , Glycine N-Methyltransferase/deficiency , Nitrosative Stress/drug effects , Oxidative Stress/drug effects , Tannins/pharmacology , Amino Acid Metabolism, Inborn Errors/metabolism , Amino Acid Metabolism, Inborn Errors/pathology , Animals , Brain/drug effects , Brain/metabolism , Glutathione Peroxidase/genetics , Glycine N-Methyltransferase/metabolism , Humans , Kidney/drug effects , Kidney/metabolism , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Nitrosative Stress/genetics , Oxidation-Reduction/drug effects , Oxidative Stress/genetics , Rats , Reactive Oxygen Species/metabolism , Serum/drug effects , Serum/metabolism , Superoxide Dismutase/genetics
7.
Food Res Int ; 137: 109573, 2020 11.
Article in English | MEDLINE | ID: mdl-33233185

ABSTRACT

Underexplored species have phytochemical potential for pharmacological and nutraceutical applications. The fruits of such species, including aracá (Psidium cattleianum Sabine), are rich in specialized metabolites with putative antioxidant and antimicrobial activity; therefore, the leaves of these species are also a potential source of bioactive compounds. In this study, araçazeiro leaves were extracted using an aqueous infusion (Al) and a pressurized liquid extraction system with water (PLE-W), ethanol (PLE-E), and 1:1 water:ethanol ratio combination (PLE-W:E). PLE-W:E yielded a greater diversity of extracted compounds. Nonetheless, all extracts showed inhibitory activity against pathogenic Gram-positive and Gram-negative bacteria and antioxidant activity in the in vitro thiobarbituric acid reactive substances (TBARS) and reactive oxygen species (ROS) assays with rat brain and yeast model systems. Thus, araçazeiro leaves can be exploited as a promising source of bioactive compounds.


Subject(s)
Anti-Infective Agents , Psidium , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Gram-Negative Bacteria , Gram-Positive Bacteria , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Plant Leaves
8.
J Food Biochem ; : e13442, 2020 Aug 17.
Article in English | MEDLINE | ID: mdl-32803896

ABSTRACT

The aim of the current study was to evaluate the effect of chronic administration of Eugenia uniflora fruit extract on behavioral parameters, oxidative stress markers, and acetylcholinesterase activity in an animal model of depression, which was induced by chronic unpredictable stress (CUS). Mice were divided into six groups as follows: control/vehicle (water), control/fluoxetine (20 mg/kg), control/extract (200 mg/kg), CUS/vehicle, CUS/fluoxetine (20 mg/kg), and CUS/extract (200 mg/kg). Animals of the CUS group were exposed to a series of stressors for a period of 21 days. Vehicle, fluoxetine, and hydroalcoholic extract were administered daily by gavage. Results showed that E. uniflora treatment: (a) prevented the depressant-like effect induced by CUS; (b) regulated the activity of acetylcholinesterase; (c) reduced oxidative damage to lipids and reactive oxygen species production, in the prefrontal cortex and hippocampus; and (d) prevented the reduction of glutathione peroxidase in the hippocampus of animals subjected to CUS protocol. Taken together, our findings suggested that E. uniflora extract exerts a neuroprotective effect by preventing oxidative damage and decreasing CUS-induced acetylcholinesterase activity, thus, ameliorating depressive-type behavior. PRACTICAL APPLICATIONS: E. uniflora fruit extract revealed an antidepressant-like effect and prevented the oxidative damage as well as cholinergic alterations caused by chronic stress in mice. Therefore, we believe that the results obtained in this study can be used to develop an alternative therapy for the management of depressive disorders.

9.
Biomarkers ; 25(5): 417-424, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32519899

ABSTRACT

Aim: This study investigated the effects of polar Butia odorata fruit extract on metabolic, inflammatory, and oxidative stress parameters in rats submitted to a hyperlipidaemia condition induced by tyloxapol.Methods: Animals were divided into 3 groups: saline, saline plus tyloxapol, and B. odorata extract plus tyloxapol. Animals were treated for 15 days with a saline solution or B. odorata fruit extract and after hyperlipidaemia was induced by tyloxapol.Results: Treatment with B. odorata extract reduced serum triglyceride, total cholesterol, C-reactive protein, and adenosine deaminase and butyrylcholinesterase activities when compared to the tyloxapol group. HDL-cholesterol and paraoxonase 1 activity were higher in B. odorata extract treated animals when compared to tyloxapol-treated animals. No differences were observed in hepatic oxidative stress parameters. Phenolic compounds present in B. odorata fruit extract were identified and quantified by LC-MS/MS.Conclusion: These findings indicated that phenolic rich B. odorata extract has hypolipidemic and anti-inflammatory effects in hyperlipidemic rats.


Subject(s)
Arecaceae/chemistry , Aryldialkylphosphatase/genetics , Liver/drug effects , Oxidative Stress/drug effects , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , C-Reactive Protein/metabolism , Cholesterol, HDL/blood , Chromatography, Liquid , Fruit/chemistry , Humans , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Male , Phenols/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Tandem Mass Spectrometry , Triglycerides/blood
10.
Redox Rep ; 23(1): 41-46, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29088999

ABSTRACT

OBJECTIVE: Insulin resistance (IR) plays an important role in the development of many diseases, such as diabetes mellitus. Therefore, the aim of the present study was to evaluate the effects of the extracts from fruits native to Brazil on metabolic parameters and hepatic oxidative markers in an animal model of insulin resistance induced by dexamethasone (DEX). METHODS: Wistar rats received water or extracts of Eugenia uniflora or Psidium cattleianum, once a day for 21 days. For the last 5 days, the rats received an intraperitoneal injection of saline or DEX. RESULTS: DEX caused a reduction in body weight gain and relative pancreatic weight, as well as glucose intolerance, and an increase in serum glucose and triacylglycerol levels. The extracts were found to prevent hyperglycemia and hypertriglyceridemia. DEX caused an increase in the levels of thiobarbituric acid-reactive substances and reactive oxygen species production in the liver of rats, and both extracts prevented these changes. In addition, hepatic glutathione peroxidase activity was reduced by DEX. However, total thiol content and activities of catalase, superoxide dismutase, and delta-aminolevulinate dehydratase were not altered in any of the tested groups. CONCLUSION: Fruit extracts of E. uniflora and P. cattleianum exhibited considerable antihyperglycemic, antidyslipidemic, and antioxidant effects, and may be useful in the therapeutic management of alterations due to IR.


Subject(s)
Antioxidants/pharmacology , Hypoglycemic Agents/pharmacology , Insulin Resistance , Plant Extracts/pharmacology , Animals , Brazil , Dexamethasone/toxicity , Disease Models, Animal , Dyslipidemias/chemically induced , Dyslipidemias/drug therapy , Enzymes/metabolism , Eugenia/chemistry , Fruit/chemistry , Hypolipidemic Agents/pharmacology , Liver/drug effects , Liver/metabolism , Male , Oxidative Stress/drug effects , Psidium/chemistry , Rats, Wistar
11.
Biomed Pharmacother ; 92: 935-941, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28618655

ABSTRACT

The aim of this study was to investigate the effect of Eugenia uniflora fruit (red type) extract on metabolic status, as well as on neurochemical and behavioral parameters in an animal model of metabolic syndrome induced by a highly palatable diet (HPD). Rats were treated for 150days and divided into 4 experimental groups: standard chow (SC) and water orally, SC and E. uniflora extract (200mg/kg daily, p.o), HPD and water orally, HPD and extract. Our data showed that HPD caused glucose intolerance, increased visceral fat, weight gain, as well as serum glucose, triacylglycerol, total cholesterol and LDL cholesterol; however, E. uniflora prevented these alterations. The extract decreased lipid peroxidation and prevented the reduction of superoxide dismutase and catalase activities in the prefrontal cortex, hippocampus and striatum of animals submitted to HPD. We observed a HPD-induced reduction of thiol content in these cerebral structures. The extract prevented increased acetylcholinesterase activity in the prefrontal cortex caused by HPD and the increase in immobility time observed in the forced swim test. Regarding chemical composition, LC/MS analysis showed the presence of nine anthocyanins as the major compounds. In conclusion, E. uniflora extract showed benefits against metabolic alterations caused by HPD, as well as exhibited antioxidant and antidepressant-like effects.


Subject(s)
Antidepressive Agents/pharmacology , Antioxidants/pharmacology , Brain/drug effects , Depression/prevention & control , Eugenia/chemistry , Fruit/chemistry , Metabolic Syndrome/prevention & control , Plant Extracts/pharmacology , Acetylcholinesterase/metabolism , Adiposity/drug effects , Animals , Antidepressive Agents/isolation & purification , Antidepressive Agents/standards , Antioxidants/isolation & purification , Antioxidants/standards , Behavior, Animal/drug effects , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Brain/metabolism , Brain/physiopathology , Catalase/metabolism , Depression/blood , Depression/physiopathology , Depression/psychology , Diet, High-Fat , Dietary Sucrose , Disease Models, Animal , Dyslipidemias/blood , Dyslipidemias/chemically induced , Dyslipidemias/prevention & control , GPI-Linked Proteins/metabolism , Glucose Intolerance/blood , Glucose Intolerance/chemically induced , Glucose Intolerance/prevention & control , Lipid Peroxidation/drug effects , Lipids/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Motor Activity/drug effects , Obesity/blood , Obesity/chemically induced , Obesity/prevention & control , Phytotherapy , Plant Extracts/isolation & purification , Plant Extracts/standards , Plants, Medicinal , Rats, Wistar , Superoxide Dismutase/metabolism , Time Factors , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...